Cascade Bio
The University of Colorado Connection
Cascade Bio’s proprietary enzyme immobilization technology, dubbed “Body Armor,” acts as a cushion for the enzyme, enabling it to last longer, withstand more challenging conditions, and work across a wider operating window than other cell-free solutions. The technology was invented by co-founder James Weltz while a graduate student in the CU Boulder laboratories of Daniel K. Schwartz (CU Boulder Chemical and Biological Engineering) and Joel Kaar (CU Boulder Chemical and Biological Engineering).
Funding Status and Investment Opportunities
- Industry: Biotech, Manufacturing
- Funding Stage: Seed Round
- Contact for Investment Inquiries: Alex Rosay, alex@cascadebio.com
In the News
- CU Boulder hosts showcases highlighting breakthrough innovations and investment-ready ventures (2025)
- The Colorado Office of Economic Development and International Trade announces grants to CU researchers and startups (2024, OEDIT)
- 2023 Destination Startup drives investment in intermountain west university innovations (2023)
- Cascade Biocatalysts secures $2.6M to scale enzymes for biomanufacturing (2023, Business Wire)
Venture Partners Programs
This page was last updated on Dec. 2, 2024. Please contact us for corrections or updates
The Insider Investor E-Newsletter
Media Inquiries
For marketing and communication inquiries, contact Daniel Leonard, senior marketing and communications specialist for Venture Partners at CU Boulder.
For media inquiries, please visit colorado.edu/news/formedia.